BioNTech, Moderna Rise On Nod To Booster For Those With Weak Immunity
BioNTech and Moderna stocks were up in early trading following the FDA authorizing Covid-19 booster
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email:uservice@ttm.financial